Classic chemistry

A simple, quantitative method to identify glycans in plasma: Mass excess distribution of tryptic peptides is mapped as a function of monoisotopic mass. Red: highly populated areas; blue: unpopulated areas; black squares: mass excesses of glycans. Credit: courtesy of Michael Bereman, Taufika Williams, and David Muddiman, North Carolina State University" />A simple, quantitative method to identify glyc

Written byJeffrey M. Perkel
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Researcher:
David Muddiman, professor of chemistry, North Carolina State University, Raleigh

Project:
Profiling O-linked glycans as biomarkers in patients with ovarian cancer

Problem:
Developing the chemistry to efficiently cleave O-linked glycans from their peptides in complex biofluids.

Solution:
After a year of effort, Muddiman has finally figured out how to adapt a standard chemical process called beta-elimination to clip O-linked glycans from proteins in biological fluids ( J Proteome Res, in press). Following purification, he then analyzes these using high-end mass spectrometers to profile the glycans' molecular weights and abundances, and to collect structural data such as branching patterns and linkages.

The approach provides significant signal amplification over techniques such as glycan-specific gel staining (see sidebar), by concentrating the glycans. "If you have the same glycan on 100 proteins and you cleave it off, you get 100-fold amplification of the signal," Muddiman says. "But if it is stuck to 100 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies